Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):326–333. doi: 10.1097/QAI.0b013e31826be75e

Figure 2.

Figure 2

Cumulative proportions of patients starting antiretroviral therapy over time for CD4 count thresholds of 500, 350 and 200 cells/μl and (A) different frequencies of CD4 count measurements, and (B) without and with a requirement for a confirmatory measurement.